AKAO 2018 Proxy Statement

48 Percentage ownership of our common stock in the table is based on 44,791,564 shares of our common stock issued and outstanding on March 31, 2018. Unless otherwise indicated, the address of each of the individuals and entities named below is c/o Achaogen, Inc., 1 Tower Place, Suite 300, South San Francisco, California 94080. Shares of Common Stock Beneficially Owned (1) Name of Beneficial Owner Common Stock Securities Exercisable Within 60 Days Number of Shares Beneficially Owned Percent 5% and Greater Stockholders: Robert W. Duggan (2) 6,463,278 — 6,463,278 14.4% Entities Affiliated with New Enterprise Associates (3) 5,215,128 1,178,782 6,393,910 14.3% Entities Affiliated with Fidelity Investments (4) 5,032,176 — 5,032,176 11.2% BlackRock, Inc. (5) 2,837,846 — 2,837,846 6.3% State Street Corporation (6) 2,383,455 — 2,383,455 5.3% Entities Affiliated with Foresite Capital Management (7) 2,375,000 — 2,375,000 5.3% Named Executive Officers and Directors: Blake Wise (8) 204,361 155,705 360,066 * Kenneth J. Hillan, M.B., Ch.B. (9) 33,651 771,792 805,443 1.8% Tobin C. Schilke (10) 9,960 73,983 83,943 * Lee Swem, Ph.D. (11) 14,932 84,457 99,389 * Gary Loeb (12) 3,707 29,225 32,932 * Ian Friedland, M.D. (13) 86,426 117,021 203,447 * Bryan E. Roberts, Ph.D. (14) 1,746,461 39,166 1,785,627 4.0% Karen Bernstein, Ph.D. (15) — 5,555 5,555 * Michael Fischbach, Ph.D. (16) — 35,832 35,832 * John C. Doyle (17) — 127,280 127,280 * Halley E. Gilbert (18) — 18,054 18,054 * Kent E. Lieginger, Pharm.D. (19) — 39,166 39,166 * John W. Smither (20) — 57,347 57,347 * Gregory Stea (21) — 38,610 38,610 * All directors and current executive officers as a group (13 persons) (22) 2,013,072 1,476,172 3,489,244 7.8% * Less than one percent of our outstanding shares of common stock. (1) Represents shares of common stock held, warrants and options held by such individuals that were exercisable within 60 days of March 31, 2018. Includes shares held in the beneficial owner’s name or jointly with others, or in the name of a bank, nominee or trustee for the beneficial owner’s account. Reported numbers do not include options that vest more than 60 days after March 31, 2018. (2) As reported on a Form 4 filed with the SEC on March 30, 2018 and Amendment No. 3 to Schedule 13D filed with the SEC on March 14, 2018 by Robert W. Duggan and Genius Inc. (“Genius”). Mr. Duggan holds 6,391,108 shares of common stock and Genius holds 72,170 shares of common stock. As the sole shareholder of Genius, Mr. Duggan may be deemed the beneficial owner of the shares held by Genius. The address for Mr. Duggan is 611 S. Fort Harrison Ave., Suite 306, Clearwater, Florida 33756. The address for Genius is 616 Druid Road East, Clearwater, Florida 33756.